Author : Douglas L. Grider
Moderna says FDA refuses to review its application for experimental flu shot
Moderna said the move is inconsistent with previous feedback from the FDA on the experimental influenza shot, called mRNA-1010....
Coca-Cola shares fall 3% after company forecasts modest growth amid demand concerns
Like rival PepsiCo, Coke has seen demand for its drinks fall as budget-conscious shoppers try to save more on their grocery bills....
Target steps up investment in store staffing, cuts about 500 other roles to help fix customer experience
The big-box retailer is trying to win back shoppers who have complained about sloppier stores, out-of-stock items and longer checkout lines....
Pressure mounts on American Airlines CEO as carrier lags rivals
American Airlines made $111 million last year, while rivals Delta Air Lines and United Airlines, brought in $5 billion and $3.3 billion, respectively....
AI companies pour big money into Super Bowl battle
Google, Amazon and Meta are among the companies advertising their AI tools during Super Bowl 60....
Goldman Sachs is tapping Anthropic’s AI model to automate accounting, compliance roles
Goldman Sachs is building AI agents with Anthropic’s Claude to automate trade accounting and client onboarding, aiming to speed work and boost efficiency....
White House launches direct-to-consumer drug site TrumpRx. Here’s what to know
It’s still unclear if all patients, particularly those with insurance coverage, will see more cost savings from using that site to buy their medicines....
Where billionaires’ investment firms placed their bets in January
David Blitzer’s family office bought a motorcycle racing team, but 2026 deal-making is not off to a roaring start....
E.l.f. Beauty posts earnings beat, raises full-year guidance
E.l.f. Beauty said its acquisition of Hailey Bieber’s skin-care company, Rhode, contributed $128 million to the company’s net third-quarter sales growth....